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Abstract 
Background: Few studies have reported the attitudes of both individual doctors and members of the 
public toward the appropriateness of ‘gifts’ from pharmaceutical companies. 
Aims: To investigate the attitudes of both doctors and members of the public toward the 
appropriateness of receiving particular ‘gifts’ from pharmaceutical companies, and to consider 
whether public acceptability is a suitable criterion for determining the ethical appropriateness of 
‘gifts’. 
Methods: A survey questionnaire of medical specialists in Australia and a survey questionnaire of 
members of the public itemised 23 ‘gifts’ (valued between AU$10 and AU$2500) and asked whether 
or not each was appropriate. 
Results: Both medical specialists and members of the public believe certain ‘gifts’ from 
pharmaceutical companies are appropriate but not others. There was a tendency for members of 
the public to be more permissive than medical specialists. 
Conclusion: Although some professional guidelines place importance on the attitudes of the general 
public to ‘gift’ giving, and other guidelines give importance to a need for transparency and public 
accountability, we question whether public acceptability is a suitable criterion for determining the 
ethical appropriateness of ‘gifts’. We suggest that more weight be given to the need for 
independence of clinical decision making, with empirical evidence indicating that even small ‘gifts’ 
can bias clinicians’ judgments, and to important values such as the primacy of patient welfare, 
autonomy and social justice. We conclude that it is time to eliminate giving and receiving of 
promotional items between the pharmaceutical industry and members of health professions. 
 
 
Introduction 
 
Interaction between physicians and the pharmaceutical industry has attracted widespread attention 
because of concern that it may subvert the goals of medicine and medical research, cause harm to 
patients, and increase the cost of healthcare.1–5 Of the many forms of interaction that may occur, 
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the giving of gifts to health professionals has been the focus of particular concern.6–16 In part this is 
because gift giving is the most obvious interaction between physicians and the pharmaceutical 
industry and in part because of the concern that it may lead to conflicts of interest and compromise 
clinical judgement. Public and professional concern about the impact of such ‘gifts’ on physicians' 
prescribing practices has led to the development of ethical codes and guidelines.17–25 These 
typically offer guidance rather than proscriptive rules and recommend restricting food and 
entertainment to modest levels, ‘gifts’ to items of low value, and advise doctors not to allow ‘gifts’ 
to influence their prescribing habits.17–25 Some commentators have noted that the term ‘gift’ is 
misleading in that ‘gifts’ are more accurately termed ‘marketing wares’11 (or at least ‘promotional 
aids’22) that are effective in influencing prescribers.1,9–11 There are increasing calls for the 
elimination of ‘gifts’ entirely11,16 with the consequence that some professional,24 pharmaceutical 
industry25 and institutional5 guidelines have advised against24,25 or prohibited5,18‘gift’ giving or 
receiving. However, most guidelines still leave the determination of the appropriateness of a specific 
gift to individual physicians.17,19–21,24 
 
Although there have been studies of patients' views,8,14,15 the basis upon which individual doctors 
make decisions about the moral acceptability of ‘gifts’ and the degree to which these concur with 
public attitudes to gift giving has rarely been systematically examined8 and has never been 
examined in the Australian context. This is particularly significant given that transparency and public 
accountability are core components of some guidelines on preventing conflicts of interest (including 
those of the Royal Australasian College of Physicians24 and the Australian Medical Association18) 
and that other guidelines (e.g. those of the American College of Physicians and American Society of 
Internal Medicine20,21) suggest that physicians should gauge the acceptability of any gift from the 
pharmaceutical industry according to what patients or the public would think about the 
arrangement. 
 
As part of a larger study investigating the relationship between the pharmaceutical industry and 
medical specialists, we undertook to describe the attitudes of medical specialists and the public to 
the receipt of ‘gifts’ from the pharmaceutical industry in order to examine more systematically 
whether the attitudes of either may be used as a reference point against which the ethical 
appropriateness of accepting gifts can be judged. 
 
Methods 
 
Data were collected through two surveys using self-report questionnaires designed specifically for 
each group. These surveys and the study methods were approved by the Human Research Ethics 
Committees of the University of Newcastle, Australia. Details of the medical specialist survey 
(including population sampling and methods) have been reported elsewhere.3,12 Briefly, the 
medical specialist questionnaire consisted of 46 questions on all aspects of the relationship with 
pharmaceutical companies, including the frequency and nature of interactions and the frequency, 
type and value of ‘gifts’ offered and received and the appropriateness of ‘gifts’ offered. In particular 
we asked respondents to rate the appropriateness of a range of 23 ‘gifts’ that medical practitioners 
may be offered by industry representatives (Table 1). These ‘gifts’ included items (such as pens, 
computers) or activities (such as dinner, expenses to attend a conference) and ranged in monetary 
value from A$10 to A$2500. Respondents were asked to indicate the extent to which they 
considered each gift ‘appropriate’ by choosing a response on a Likert scale. 
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Table 1.  Hypothetical ‘gifts’ from a pharmaceutical company to doctors as presented in 
Questionnaires Forms A & B in order of value† 
   
 1. Patient information leaflets on new drug (value $10) (both Forms) 
 2. Two boxes of chocolates for doctor and surgery staff (value $10) (Form B) 
 3. Small flashlight (value $10) (Form B) 
 4. Ticket to movies (value $15) (Form B) 
 5. Pens for the surgery (value $10). Plain without promotional logos–to be used by doctor and the 
receptionists. (Form B) 
 6. Pens with the name of a new drug printed on them (value $10). Doctor and receptionists will use. (Form A) 
 7. Two appointment books (value $10) to be used to track appointments for all doctors in surgery. (Form A) 
 8. Two movie tickets for doctor and partner (value $25). (Form A) 
 9. Sample packs of new medicine (value $100). (both Forms) 
10. Set of electric scales (value $100) to be used by all doctors and nurse in surgery, to measure their patients' 
weight. (Form B) 
11. Stethoscope (value $100). (Form B) 
12. Two tickets to theatre for doctor and partner (value $100). (Form B) 
13. Ticket to football grand final (value $100). (Form A) 
14. Dinner at a city restaurant for doctor and partner (value $100)–with presentation about a new drug. (Form 
A) 
15. Lunch for doctor and all surgery staff (value $100)–with presentation about a new drug. (Form B) 
16. Dinner at a city restaurant (value $100) for doctor and partner to allow local doctors to meet and socialise. 
(Both forms) 
17. Lunch for doctor and surgery staff (value $100). (Form A) 
18. Conference including conference fees, accommodation, and airfares (value $1000). (Form B) 
19. Trip for doctor and partner to attend a conference including conference fees, accommodation and airfares 
(value $1200). Partner will not attend conference. (Form A) 
20. New refrigerator for surgery (value $2000) for use in staff lunchroom. (Form B) 
21. New laptop computer (value $2500) for use at home. (Form A) 
22. Computer (value $2500) for use by doctor to write prescriptions and keep patients' notes. (Form A) 
23. Spirometer (value $2500) to be used by all of doctors in surgery. (Form A-Medical Specialist' Questionnaire 
only) 
24. An electrocardiogram machine to monitor patents' heart rhythms (value $2500) (Form A-General Public 
Questionnaire only) 
† : All $ values = Australian dollars. 
 
The questionnaire for members of the public had a total of 20 questions seeking information on: the 
extent of their knowledge of the relationships between medical specialists and pharmaceutical 
companies; any concerns they may have about that relationship; their views on whether regulation 
of ‘gifts’ was needed; their attitudes to pharmaceutical company sponsored research; and personal 
demographics, including their level of education, health status, recent visits to a doctor, receipt of 
free medication and participation in research trials. As in the medical specialist survey, public 
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respondents were asked to rate the appropriateness of the (same) range of 23 ‘gifts’ that medical 
practitioners may be offered by industry representatives. 
 
Differences between medical professionals and the general public (such as lack of familiarity among 
the general public with the physician–industry relationship, the nature of gifts that might be offered 
to doctors, experience with responding to survey instruments using Likert scales) necessitated some 
differences in the presentation of the question regarding gift appropriateness. Medical specialists 
were asked to indicate their level of agreement on a 5-point Likert scale (strongly agree, agree, 
neither agree nor disagree, disagree, strongly disagree) that receiving each of 23 hypothetical gifts 
was appropriate. Members of the public were asked to indicate the appropriateness of doctors 
receiving each of the 23 gifts on a simpler 4-point Likert scale (Always appropriate to accept; 
Sometimes appropriate to accept; Never appropriate to accept; Not sure). 
 
For both medical specialists and the general public, 13 hypothetical ‘gifts’ were listed, from the full 
list of 23 ‘gifts’, in each of two versions of the questionnaire (Forms A and B). This was done to 
reduce response fatigue. Three items (‘patient information leaflets’, ‘dinner for doctor and partner 
to socialise with other doctors’, and ‘free samples of a new medicine’) were common to both Forms. 
The 13 items in each version of the questionnaire were presented in random order and participants 
were assigned at random to receive Form A or B. 
 
Results 
 
The medical specialists' questionnaire was mailed to 2253 listed specialists,3,12 of whom 133 were 
found to be ineligible (deceased, emigrated or retired). A total of 832 (447 Form A, 376 Form B) 
questionnaires was completed and returned, giving an overall response rate of 39%. The 
respondents were similar to the original sample in terms of geographic location and clinical 
specialty. The average age was 49.9 (SD 10.6) years and 79% were male. Medical specialists (but not 
members of the public) were asked if they were aware of published guidelines on interactions with 
the pharmaceutical industry. There were 546 medical specialist (66%) who stated they were aware, 
and 321 (38%) who specified one or more particular guidelines, including those of the Royal 
Australasian College of Physicians (n= 254); other specialist colleges (n= 47); Australian Medical 
Association (n= 19); Medicines Australia – pharmaceutical industry guidelines (n= 15); governmental 
guidelines (n= 10); hospital or other institutional guidelines (n= 9); USA, UK, or other international 
guidelines (n= 7). 
 
The public survey was mailed to 3000 people over the age of 18 years randomly sampled from the 
electoral roll of the Hunter region of New South Wales. Of these, 108 were returned as 
undeliverable, and 757 questionnaires were completed and returned (382 Form A, 375 Form B) 
giving an overall response rate of 26%. The average age of respondents was 52.2 (SD 16.2) years; the 
majority (59%) was female; and 20% had a university degree or were currently attending a 
university. By comparison with the wider population in New South Wales, these respondents tended 
to be older, better educated, and more likely to be female.26 On χ2 and Bayes factor tests there was 
no statistical difference between answers to the three ‘hypothetical gifts’ that were common to both 
Form A and Form B in either the general public or the medical specialist questionnaires. 
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Table 2 provides a comparison of the responses of the public and medical specialists by the 
proportions judging each nominated gift appropriate or otherwise and also shows the ranking of 
each gift from most to least appropriate. The proportions of members of the public who ‘always’ or 
‘sometimes’ considered it appropriate to accept each of the ‘gifts’ ranged from a low of 15% (for two 
movie tickets) to a high of 96% (for patient information leaflets on drugs). Near unanimity was 
reached on the appropriateness of accepting two ‘gifts’ (patient information leaflets and drug 
samples), large majorities (70% or more) judged 17 ‘gifts’ as clearly appropriate or inappropriate, 
while for six ‘gifts’ there was no clear agreement as to the appropriateness of these ‘gifts’ in that a 
third to two-thirds of respondents differed in their judgements of appropriateness. 
Table 2.  Percentage of members of general public and medical specialists agreeing it is 
appropriate to accept nominated ‘gifts’ from industry† 
 % of general public 
agree 
‘sometimes’+‘always’ 
appropriate 
General 
public 
Rank 
% of medical 
specialists 
‘agree’+‘strongly 
agree’ 
appropriate 
Medical 
specialists 
Rank 
Patient information leaflets ($10) 96 1 63 2 
Drug samples ($100) 92 2 75 1 
Appointment books ($10) 86 3 48 7 
Flashlight to examine patients ($10) 85 4 50 5= 
Lunch for doctor and staff‡ ($100) 83 5§ 25 15§ 
Pens with logo ($10) 82 6 60 3= 
Spirometer/ECG machine¶ ($2500) 80 7=§ 26 14§ 
Stethoscope ($100) 80 7=§ 33 12§ 
Pens no logo ($10) 77 9§ 60 3=§ 
Conference with partner ($1200) 76 10§ 20 17§ 
Conference doctor only ($1000) 75 11 40 9 
Lunch and lecture with staff ($100) 66 12 35 11 
Dinner and lecture with partner ($100) 60 13§ 44 8§ 
Chocolates ($10) 54 14 36 10 
Electric scales for patients ($100) 35 15§ 50 5=§ 
Computer for surgery ($2500) 34 16=§ 8 21=§ 
Dinner with partner social ($100) 34 16= 28 13 
Theatre tickets with partner ($100) 30 18 13 20 
Football ticket ($100) 28 19 17 18= 
Refrigerator for staff room ($2000) 24 20 8 21= 
Movie ticket ($15) 23 21 17 18= 
Laptop for home ($2500) 18 22 4 23 
Two movie tickets ($25) 15 23§ 21 16§ 
 
    †:     All $ values = Australian dollars. 
    ‡:     ‡Purpose not specified. 
    §:     §Ranking where there is a difference of five or more places between general public and medical 
specialists. 
    ¶:     ¶Medical specialists judged appropriateness of spirometer where as general public judged 
appropriateness of ECG machine. ECG, electrocardiogram. 
 
The proportions of medical specialists who ‘strongly agreed’ and ‘agreed’ that it was appropriate to 
accept the various suggested ‘gifts’ ranged from 4% (laptop for home) to 75% (drug samples). 
Among medical specialists near unanimity was reached on the inappropriateness of accepting a 
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laptop for personal use, a computer or a refrigerator for the surgery. Large majorities (70% or more) 
judged 10 other ‘gifts’ as clearly appropriate or inappropriate while for 13 ‘gifts’ there was no clear 
agreement as to their appropriateness in that a third to two-thirds of respondents differed in their 
judgements. 
 
For public respondents, patient information leaflets, drug samples and appointment books were 
ranked as the most appropriate ‘gifts’ for practitioners to accept and movie tickets and a laptop 
computer for home use as the least appropriate. For medical specialists, drug samples, patient 
information leaflets and pens were ranked as the most appropriate ‘gifts’ to accept while a 
computer and refrigerator for the surgery and a laptop computer for home use were ranked as the 
least appropriate. For nine of the nominated ‘gifts’, there was a substantial difference in ranking 
between medical specialists and the public with a difference of five or more places between their 
rankings. These are indicated, in each case, by a section mark (§) in Table 2. Of these nine, there 
were four ‘gifts’ in which there was both a five (or more) point difference in ranking and a difference 
of approximately 50% (47–58%) in the proportions of those finding the gift appropriate between 
members of the public and medical specialists. These four were: lunch for doctor and staff; 
spirometer/electrocardiogram machine; conference with partner; and stethoscope. 
 
Discussion 
 
The results of our study make it clear that both medical specialists and members of the public 
believe that it is acceptable for doctors to accept certain ‘gifts’ but not others. While consensus on 
the appropriateness (or otherwise) of some ‘gifts’ exists within and between groups there also exists 
some divergence on some of those ‘gifts’. Overall, public respondents appeared to be more 
permissive about doctors accepting ‘gifts’ from pharmaceutical companies than do medical specialist 
respondents. There were four ‘gifts’ in which there was both a five (or more) point difference in 
ranking between members of the public and medical specialists and a difference of approximately 
50% in the proportions of those finding the gift appropriate between the two groups. For each of 
these four ‘gifts’ (lunch for doctor and staff, spirometer/ECG machine, conference with partner, and 
stethoscope) it was the public that was more accepting. 
 
Public respondents appear to have judged the acceptability of ‘gifts’ according to a perception of 
their (more or less direct) relevance to medical practice. This conclusion is based on the observation 
that ‘gifts’ of equipment that have a parallel domestic use (e.g. electric scales, refrigerator, laptop 
computer) were judged appropriate by much smaller proportions of public respondents than ‘gifts’ 
of unambiguously clinical items, such as stethoscopes. Medical specialists, on the other hand, appear 
to have considered a wide range of factors, including the value of the gift, its relevance to patient 
care, and whether or not the gift extended to others (staff or partners). The items that 50% (or 
more) of medical specialists agreed were appropriate were either very low cost (pens valued at 
A$10, patient information leaflets valued at A$10) or relatively low cost and directly relevant to 
patient care (drug samples valued at A$100, and electric scales valued at A$100). Medical specialists 
were less accepting of moderate cost and expensive ‘gifts’ even when the equipment was specific to 
medicine (stethoscope and spirometer). Neither medical specialists nor members of the public were 
supportive of any ‘gifts’ that were clearly not relevant to medicine (laptop computer, tickets to 
theatre, sporting events) even when the cost of these was minimal (movie tickets). 
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It is worth noting however that a minority of medical specialists in our study considered ‘gifts’ 
appropriate that were not acceptable within the current guidelines.27 For example, a small 
percentage agreed that it is appropriate to accept: a laptop computer for home use; a computer for 
the surgery; theatre tickets including partner; a ticket to a football grand final; and a trip with 
partner to attend a conference. This information should be of concern to the relevant colleges in 
their attempts to establish standards for ethical relationships between medical practitioners and 
industry. 
 
A number of qualifications need to be made to our findings. First, given an overall response rate of 
39% for medical specialists and 26% for members of the general public (a difficulty shared with other 
mail surveys28), we are unable to rule out a ‘response bias’. It is possible that those with a particular 
interest in the relationship between pharmaceutical companies and the medical profession were 
more inclined to respond and their answers may differ from those of the wider populations from 
which they were drawn. In addition, our public sample was drawn from the Hunter area in New 
South Wales and it is possible that this region is not representative of the Australian population 
although we have no reason for believing that views about gifts to doctors are atypical in this area. 
As this survey was based on self-reports we also cannot be certain that answers given by medical 
specialists, regarding the acceptability of ‘gifts’, reflected their behaviour. We have also indicated 
(above) a caution in comparing two different datasets when the questions put to members of the 
public were not identical in form to the questions put to medical specialists and there were 
differences in the response scales. While the overall trends identified by the two groups may be 
compared, any direct comparison between the two groups in relation to any particular item must be 
made with caution. Although we have made some comparisons between the two groups, we have 
confined our specific comments to those items for which there were large differences in the 
rankings (≥5 places) and large differences between the two groups in the proportions (≥47%) of 
those judging the gift to be appropriate. 
 
The major findings from this study are similar to those of Gibbons et al.8 which found that both 
medical specialists and members of the public accept that some low or moderate cost items of clear 
and direct benefit to patients (e.g. drug samples and patient information leaflets) are appropriate. 
However, unlike the Gibbons study, we found a greater tendency for members of the public, rather 
than physicians, to regard ‘gifts’ as appropriate. In our study a high proportion of members of the 
public regarded items of direct relevance to medicine to be appropriate ‘gifts’, including an 
expensive item of equipment (ECG machine valued at A$2500). 
 
The reason for this tendency for the public to be more accepting of some ‘gifts’ in our study is 
unclear. Possible explanations include differences between the public and medical specialists in 
awareness of the issues surrounding pharmaceutical industry influence on prescribing, a growing 
awareness among medical specialists of the potential for ‘gifts’ to bias doctors' judgements, and 
differences in awareness of ethical guidelines that advise against receiving ‘gifts’ of this kind. It may 
also be the case that the Australian public has a greater degree of trust in the capacity of physicians 
to act always in the best interest of their patients and to make decisions unbiased by ‘gifts’ from 
pharmaceutical companies than physicians have towards themselves and their colleagues. Whatever 
the explanation, we found that the majority of medical specialists in our study were more in line 
with current ethical guidelines and less inclined to regard ‘gifts’ from the pharmaceutical industry as 
appropriate than members of the general public. 
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There is a broader question, however, which is raised by this study. This is the question of whether 
public acceptability is a suitable criterion for determining the ethical appropriateness of ‘gifts’. While 
we do not suggest that public acceptance is irrelevant we would be very concerned if these findings 
were taken to suggest that a more liberal attitude to gift giving by pharmaceutical companies is 
indicated. In our view the ethical appropriateness of giving and receiving ‘gifts’ cannot be 
determined simply by reference to the prevailing attitudes of either the profession or the public. It is 
well understood within moral philosophy that consensus on an issue is not determinative of its 
moral worth. Popular support for racist policies for example does not make them morally justifiable. 
Similarly, a finding that 80% of the general public would consider it appropriate for a doctor to 
accept a gift of an ECG machine does not determine its ethical appropriateness. In our view 
judgements about the ethical appropriateness of giving and receiving ‘gifts’ should give more weight 
to important values (such as the primacy of patient welfare, autonomy, and social justice5), the need 
for independence of clinical decision-making, and empirical evidence indicating that even small 
‘gifts’ can bias clinicians' judgements.1,8–10 For all these reasons we consider that any notion that a 
commitment to transparency and public accountability18,24 is sufficient to prevent conflicts of 
interest, or that the real or perceived attitudes of the general public to ‘gift’ giving may be used as a 
standard against which a doctor should gauge the acceptability of a gift,19 is both simplistic and 
flawed. The finding of our own study, that medical specialists and members of the public regard 
some ‘gifts’ as appropriate, has to be weighed against the strong case against allowing any ‘gifts’ as 
promotional items for doctors.5,11,16,18 
 
Our results reveal a relatively liberal public and professional approach to the receipt of some ‘gifts’ 
by the medical profession. Those attitudes are at odds with evidence (cited above) that harm may 
result from these activities. On this basis, and in keeping with other commentators,11,16 we are 
persuaded that it is time to eliminate giving and receiving of promotional items between the 
pharmaceutical industry and members of the health professions. 
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